|
Market Closed -
NSE India S.E.
08:22:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 5,113.50 INR | +0.68% |
|
+3.37% | -7.14% |
| 10-12 | Alkem Laboratories Limited Announces Management Appointments, Effective October 12, 2026 | CI |
| 09-24 | Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer | CI |
Business description: Alkem Laboratories Limited
Number of employees: 19,346
Sales by Activity: Alkem Laboratories Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
Pharmaceuticals | 106B | 116B | 127B | 130B | 147B |
Geographical breakdown of sales: Alkem Laboratories Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
India | 75.27B | 81.6B | 86.62B | 91.44B | 99.75B |
United States (US) | 23.29B | 25.13B | 27.71B | 24.82B | 29.62B |
Other International | 7.78B | 9.26B | 12.35B | 13.39B | 17.75B |
Executive Committee: Alkem Laboratories Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Rajorshi Ganguli
PSD | President | - | - |
Akhilesh Sharma
PSD | President | - | - |
| Chief Operating Officer | - | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
Ashish Sehgal
CTO | Chief Tech/Sci/R&D Officer | - | - |
Composition of the Board of Directors: Alkem Laboratories Limited
| Director | Title | Age | Since |
|---|---|---|---|
Sandeep Singh
BRD | Director/Board Member | 44 | 2013-08-08 |
| Director/Board Member | 63 | 2008-02-10 | |
Sarvesh Singh
BRD | Director/Board Member | 45 | 2019-11-10 |
| Director/Board Member | 73 | 2020-03-15 | |
| Chairman | 86 | - | |
Madhurima Singh
BRD | Director/Board Member | - | 2021-12-19 |
Srinivas Singh
BRD | Director/Board Member | - | 2022-09-13 |
| Director/Board Member | 62 | 2022-08-04 | |
Rajeev Kher
BRD | Director/Board Member | 71 | 2024-08-08 |
| Director/Board Member | 78 | 2015-03-15 |
Company details: Alkem Laboratories Limited
Alkem Laboratories Ltd.
Devashish Building, Alkem House
400013, Mumbai
+91 22 3982 9999
http://www.alkemlabs.com
Group companies: Alkem Laboratories Limited
| Name | Category and Sector |
|---|---|
Indchemie Health Specialities Pvt Ltd.
 Indchemie Health Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products |
Pharmaceuticals: Major
|
Ascend Laboratories LLC
 Ascend Laboratories LLC Pharmaceuticals: GenericHealth Technology Manufactures generic medicines |
Pharmaceuticals: Generic
|
The Pharma Network LLP | |
Ascend Laboratories SpA
 Ascend Laboratories SpA Pharmaceuticals: MajorHealth Technology Manufactures, sells and retails bioequivalent drugs that improve the health and well-being of patients |
Pharmaceuticals: Major
|
S&B Pharma LLC |
Pharmaceuticals: Other
|
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | +3.37% | -7.14% | +37.39% | 6.44B | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.94% | +5.65% | +41.21% | +79.84% | 426.84B | |
| Weighted average by Cap. | +2.00% | +6.59% | +50.42% | +100.34% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALKEM Stock
- Company Alkem Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
